Metabolic syndrome and insulin resistance in subjects with morbid obesity

Obesity Surgery

Volumn 20, Issue 3, 2010, Pages 295-301

  Soverini, Valentina ^a   Moscatiello, Simona ^a   Villanova, Nicola ^a   Ragni, Elisabetta ^a   Di Domizio, Silvia ^a   Marchesini, Giulio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hypertension; Insulin resistance; Lipid profile; Liver enzymes; Metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CONFIDENCE INTERVALS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; ITALY; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; WAIST CIRCUMFERENCE;

EID: 77949266545     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-9999-z     Document Type: Article

References (47)

1. WHO Global InfoBase team. The SuRF Report 2. Surveillance of chronic disease risk factors: country level data and comparable estimates. Geneva: World Health Organization; 2005.
2. W Rosamond K Flegal G Friday, et al. 2007 Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation. 115 e69 171 10.1161/CIRCULATIONAHA.106.179918 17194875 (Pubitemid 46226160)
3. Y Wang MA Beydoun 2007 The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis Epidemiol Rev. 29 6 28 10.1093/epirev/mxm007 1:CAS:528:DC%2BD1cXhtFSntb3L 17510091 (Pubitemid 47229643)
4. G Whitlock S Lewington P Sherliker, et al. 2009 Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet. 373 1083 96 10.1016/S0140-6736(09)60318-4 19299006
5. S Yusuf S Hawken S Ounpuu, et al. 2005 Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study Lancet. 366 1640 9 10.1016/S0140-6736(05)67663-5 16271645 (Pubitemid 41552419)
6. Hu FB. Obesity epidemiology. Oxford: Oxford University Press; 2008.
7. P Maison CD Byrne CN Hales, et al. 2001 Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature Diabetes Care. 24 1758 63 10.2337/diacare.24.10.1758 1:STN:280:DC%2BD3MrivVWjtg%3D%3D 11574438
8. SM Grundy HB Brewer Jr JI Cleeman, et al. 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation. 109 433 8 10.1161/01.CIR.0000111245.75752.C6 14744958 (Pubitemid 38133916)
9. G Marchesini N Melchionda G Apolone, et al. 2004 The metabolic syndrome in treatment-seeking obese persons Metabolism. 53 435 40 10.1016/j.metabol.2003. 10.026 1:CAS:528:DC%2BD2cXisVSmu70%3D 15045688 (Pubitemid 38419184)
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care. 20 1183 97
11. C Bogardus S Lillioja DM Mott, et al. 1985 Relationship between degree of obesity and in vivo insulin action in man Am J Physiol. 248 E286 91 1:CAS:528:DyaL2MXhsVOjtLc%3D 3883799
12. F Abbasi BW Brown Jr C Lamendola, et al. 2002 Relationship between obesity, insulin resistance, and coronary heart disease risk J Am Coll Cardiol. 40 937 43 10.1016/S0735-1097(02)02051-X 1:CAS:528:DC%2BD38Xns1OmsLg%3D 12225719 (Pubitemid 34994988)
13. H Tilg AR Moschen 2008 Inflammatory mechanisms in the regulation of insulin resistance Mol Med. 14 222 31 10.2119/2007-00119.Tilg 1:CAS:528:DC%2BD1cXksVensrk%3D 18235842
14. PT Katzmarzyk I Janssen R Ross, et al. 2006 The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men Diabetes Care. 29 404 9 10.2337/diacare.29.02.06.dc05-1636 16443895
15. AC St-Pierre B Cantin P Mauriege, et al. 2005 Insulin resistance syndrome, body mass index and the risk of ischemic heart disease CMAJ. 172 1301 5 15883404
16. KE Kip OC Marroquin DE Kelley, et al. 2004 Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study Circulation. 109 706 13 10.1161/01.CIR.0000115514.44135.A8 14970104 (Pubitemid 38222888)
17. G Iacobellis MC Ribaudo A Zappaterreno, et al. 2005 Prevalence of uncomplicated obesity in an Italian obese population Obes Res. 13 1116 22 10.1038/oby.2005.130 15976155
18. AD Karelis M Brochu R Rabasa-Lhoret 2004 Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 30 569 72 10.1016/S1262-3636(07)70156-8 1:STN:280:DC%2BD2M%2FktlagsA%3D%3D 15671927
19. RP Wildman P Muntner K Reynolds, et al. 2008 The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch Intern Med. 168 1617 24 10.1001/archinte.168.15.1617 18695075
20. MP St-Onge I Janssen SB Heymsfield 2004 Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care. 27 2222 8 10.2337/diacare.27.9.2222 15333488 (Pubitemid 39167189)
21. E Succurro MA Marini S Frontoni, et al. 2008 Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals Obesity (Silver Spring, Md). 16 1881 6 10.1038/oby.2008.308 1:CAS:528:DC%2BD1cXptFOrtb4%3D
22. EA Sims 2001 Are there persons who are obese, but metabolically healthy? Metabolism. 50 1499 504 10.1053/meta.2001.27213 1:CAS:528:DC%2BD3MXptVGhtb0%3D 11735101 (Pubitemid 34007425)
23. SH Kim F Abbasi GM Reaven 2004 Impact of degree of obesity on surrogate estimates of insulin resistance Diabetes Care. 27 1998 2002 10.2337/diacare.27. 8.1998 15277430 (Pubitemid 38989245)
24. SM Grundy JI Cleeman SR Daniels, et al. 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation. 112 2735 52 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
25. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet. 366 1059 62 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
26. DR Matthews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man Diabetologia. 28 412 9 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
27. E Bugianesi U Pagotto R Manini, et al. 2005 Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity J Clin Endocrinol Metab. 90 3498 504 10.1210/jc.2004-2240 1:CAS:528:DC%2BD2MXkvFCltLs%3D 15797948 (Pubitemid 41014319)
28. A Mari G Pacini E Murphy, et al. 2001 A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care. 24 539 48 10.2337/diacare.24.3.539 1:CAS:528:DC%2BD3MXit1erurc%3D 11289482
29. G Svegliati-Baroni E Bugianesi T Bouserhal, et al. 2007 Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease Gut. 56 1296 301 10.1136/gut.2006.107946 1:CAS:528:DC%2BD2sXhtVKgsbbI 17392334 (Pubitemid 47300433)
30. T McLaughlin G Reaven F Abbasi, et al. 2005 Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 96 399 404 10.1016/j.amjcard.2005.03.085 1:CAS:528:DC%2BD2MXmvVWltr0%3D 16054467 (Pubitemid 41058868)
31. C Li ES Ford YX Meng, et al. 2008 Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol. 7 4 10.1186/1475-2840-7-4 18307789 (Pubitemid 351552585)
32. E Bonora G Targher M Alberiche, et al. 2000 Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care. 23 57 63 10.2337/diacare.23.1.57 1:STN:280:DC%2BD3czpsVyisA%3D%3D 10857969
33. H Yki-Jarvinen J Westerbacka 2005 The fatty liver and insulin resistance Curr Mol Med. 5 287 95 10.2174/1566524053766031 1:STN:280:DC%2BD2M3ltlensg%3D%3D 15892648 (Pubitemid 40667509)
34. KF Petersen S Dufour D Befroy, et al. 2005 Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes. 54 603 8 10.2337/diabetes.54.3.603 1:CAS:528:DC%2BD2MXitlehu7s%3D 15734833 (Pubitemid 40322060)
35. ML Petroni N Villanova S Avagnina, et al. 2007 Psychological distress in morbid obesity in relation to weight history Obes Surg. 17 391 9 10.1007/s11695-007-9069-3 17546849 (Pubitemid 46659301)
36. AD Karelis DH St-Pierre F Conus, et al. 2004 Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 89 2569 75 10.1210/jc.2004-0165 1:CAS:528:DC%2BD2cXmtlGqt7Y%3D 15181025 (Pubitemid 38766333)
37. M Brochu A Tchernof IJ Dionne, et al. 2001 What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 86 1020 5 10.1210/jc.86.3.1020 1:CAS:528:DC%2BD3MXitFWnsL8%3D 11238480 (Pubitemid 32322976)
38. S Schinner K Kempf H Overmann, et al. 2008 Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia Exp Clin Endocrinol Diabetes. 116 Suppl 1 S64 9 10.1055/s-2008-1081490 1:CAS:528:DC%2BD1cXhtlCgsr%2FI 18777458
39. World Health Organization. Preventing and managing the global epidemic: report of a WHO consultation. Geneva: World Health Organization; 2000. Report No.: 894.
40. AD Karelis M Faraj JP Bastard, et al. 2005 The metabolically healthy but obese individual presents a favorable inflammation profile J Clin Endocrinol Metab. 90 4145 50 10.1210/jc.2005-0482 1:CAS:528:DC%2BD2MXmtlCitbY%3D 15855252 (Pubitemid 41058189)
41. G Marchesini M Brizi G Bianchi, et al. 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes. 50 1844 50 10.2337/diabetes.50.8.1844 1:CAS:528:DC%2BD3MXlslKmsr4%3D 11473047
42. JM Clark FL Brancati AM Diehl 2003 The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol. 98 960 7 10.1111/j.1572-0241.2003.07486.x 1:CAS:528:DC%2BD3sXksVentro%3D 12809815 (Pubitemid 36733754)
43. G Marchesini E Bugianesi G Forlani, et al. 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology. 37 917 23 10.1053/jhep.2003.50161 12668987 (Pubitemid 36397405)
44. P Angulo 2006 NAFLD, obesity, and bariatric surgery Gastroenterology. 130 1848 52 10.1053/j.gastro.2006.03.041 16697746 (Pubitemid 43668867)
45. M Machado P Marques-Vidal H Cortez-Pinto 2006 Hepatic histology in obese patients undergoing bariatric surgery J Hepatol. 45 600 6 10.1016/j.jhep.2006. 06.013 16899321 (Pubitemid 44307393)
46. P Marceau S Biron FS Hould, et al. 1999 Liver pathology and the metabolic syndrome X in severe obesity J Clin Endocrinol Metab. 84 1513 7 10.1210/jc.84.5.1513 1:CAS:528:DyaK1MXjtFClur0%3D 10323371
47. P Mathurin F Gonzalez O Kerdraon, et al. 2006 The evolution of severe steatosis after bariatric surgery is related to insulin resistance Gastroenterology. 130 1617 24 10.1053/j.gastro.2006.02.024 16697725 (Pubitemid 43668847)